IL177703A0 - Method of evaluating the therapeutic potential of a vaccine for mucosal administration - Google Patents
Method of evaluating the therapeutic potential of a vaccine for mucosal administrationInfo
- Publication number
- IL177703A0 IL177703A0 IL177703A IL17770306A IL177703A0 IL 177703 A0 IL177703 A0 IL 177703A0 IL 177703 A IL177703 A IL 177703A IL 17770306 A IL17770306 A IL 17770306A IL 177703 A0 IL177703 A0 IL 177703A0
- Authority
- IL
- Israel
- Prior art keywords
- vaccine
- evaluating
- therapeutic potential
- mucosal administration
- mucosal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54845404P | 2004-02-26 | 2004-02-26 | |
DKPA200400310 | 2004-02-26 | ||
US55909504P | 2004-04-02 | 2004-04-02 | |
PCT/DK2005/000123 WO2005083385A2 (en) | 2004-02-26 | 2005-02-24 | Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
IL177703A0 true IL177703A0 (en) | 2006-12-31 |
Family
ID=34915878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL177703A IL177703A0 (en) | 2004-02-26 | 2006-08-24 | Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1718974A2 (en) |
JP (1) | JP2007524096A (en) |
AU (1) | AU2005217696B2 (en) |
BR (1) | BRPI0508078A (en) |
CA (1) | CA2556557A1 (en) |
IL (1) | IL177703A0 (en) |
RU (1) | RU2006134031A (en) |
WO (1) | WO2005083385A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005217696B2 (en) * | 2004-02-26 | 2008-02-14 | Alk-Abello A/S | Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
EP1974745B1 (en) | 2007-03-28 | 2011-08-31 | Alk-Abelló A/S | Use of an adjuvanted allergy vaccine formulation for subcutaneous administration |
CA2682054A1 (en) * | 2007-03-28 | 2008-10-02 | Alk-Abello A/S | Use of an adjuvanted allergy vaccine formulation for parenteral administration |
DE202008006598U1 (en) * | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergy vaccine formulation for mucosal administration |
CN109952510A (en) | 2016-05-13 | 2019-06-28 | 应用酵素医学研究所株式会社 | Collect the method for predicting the data of all allergies risk |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021031A1 (en) * | 1991-05-10 | 1992-11-26 | Alain De Weck | PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS |
US7888458B1 (en) * | 1993-11-30 | 2011-02-15 | John B. Harley | Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
CA2335615C (en) * | 1998-06-24 | 2010-08-10 | Alk-Abello A/S | Method of detecting an antibody in a liquid sample |
AU1960100A (en) * | 1999-01-06 | 2000-07-24 | Mcmaster University | Method of preventing immune and hypersensitivity reactions |
SE0004892D0 (en) * | 2000-12-29 | 2000-12-29 | Pharmacia Diagnostics Ab | Group 2 allergen specific IgE-Fabs and use thereof |
GB0215710D0 (en) * | 2002-07-05 | 2002-08-14 | Isis Innovation | Diagnostic method |
UA62780A (en) * | 2003-05-22 | 2003-12-15 | Univ Oo Bohomolets Nat Medical | Method for estimating efficiency of vaccination against diphtheria in children with allergic diathesis |
AU2005217696B2 (en) * | 2004-02-26 | 2008-02-14 | Alk-Abello A/S | Method of evaluating the therapeutic potential of a vaccine for mucosal administration |
-
2005
- 2005-02-24 AU AU2005217696A patent/AU2005217696B2/en not_active Ceased
- 2005-02-24 BR BRPI0508078-9A patent/BRPI0508078A/en not_active IP Right Cessation
- 2005-02-24 WO PCT/DK2005/000123 patent/WO2005083385A2/en active Application Filing
- 2005-02-24 JP JP2007500050A patent/JP2007524096A/en active Pending
- 2005-02-24 RU RU2006134031/15A patent/RU2006134031A/en not_active Application Discontinuation
- 2005-02-24 EP EP05706785A patent/EP1718974A2/en not_active Withdrawn
- 2005-02-24 CA CA002556557A patent/CA2556557A1/en not_active Abandoned
-
2006
- 2006-08-24 IL IL177703A patent/IL177703A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005083385A2 (en) | 2005-09-09 |
WO2005083385A3 (en) | 2005-11-17 |
AU2005217696B2 (en) | 2008-02-14 |
RU2006134031A (en) | 2008-04-10 |
CA2556557A1 (en) | 2005-09-09 |
JP2007524096A (en) | 2007-08-23 |
EP1718974A2 (en) | 2006-11-08 |
AU2005217696A1 (en) | 2005-09-09 |
BRPI0508078A (en) | 2007-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200804918B (en) | Therapeutic vaccine | |
TWI365191B (en) | Vaccine | |
GB0526291D0 (en) | Therapeutic method | |
ZA200609105B (en) | Vaccine for periodontal disease | |
GB0409940D0 (en) | Vaccine | |
SI1765387T1 (en) | NEEDLE-FREE ADMINISTRATION OF FeLV VACCINES | |
HK1214534A1 (en) | Influenza vaccination | |
HK1088259A1 (en) | Potential therapeutic apparatus | |
IL177703A0 (en) | Method of evaluating the therapeutic potential of a vaccine for mucosal administration | |
HK1088260A1 (en) | Potential therapeutic apparatus | |
GB2460969B (en) | Vaccines for intranasal administration | |
GB0411150D0 (en) | Vaccine | |
GB0423800D0 (en) | New pharmaceutical formulations | |
EP1791506A4 (en) | Methods of device-assisted drug delivery | |
GB0413510D0 (en) | Vaccine | |
GB0412407D0 (en) | Vaccine | |
GB0428381D0 (en) | Vaccine | |
GB0420250D0 (en) | Method for oral drug delivery | |
GB0406598D0 (en) | Vaccine | |
GB0419918D0 (en) | Vaccine | |
GB0312122D0 (en) | Therapeutic method | |
EP1793848A4 (en) | Method for determining dosage for an oral killed vaccine | |
GB0420828D0 (en) | Therapeutic method | |
GB0420822D0 (en) | Therapeutic method | |
GB0420823D0 (en) | Therapeutic method |